ERBB2 and breast neoplasm: Fan et al [34] developed a combined radiomic signature that integrates intratumoral and peritumoral features to predict the HER-2 and Ki-67 status of breast tumors; this signature had AUCs of 0.848 and 0.800, respectively, in the validation cohort.